Bishop Hans Edgar — SEC insider filings

SEC reporting owner CIK 1480212. 39 insider filings on record with FilingPulse; latest filed 2026-10-06.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2021-02-05 to 2026-10-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sana Biotechnology, Inc. (SANA)Director28——31
Lyell Immunopharma, Inc. (LYEL)Director7——10
AGILENT TECHNOLOGIES, INC. (A)Director4——8

Insider filings — Bishop Hans Edgar

FiledFormIssuerReported transactionsSource
2026-10-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 8,680 @ $0EDGAR
2026-07-074Sana Biotechnology, Inc. (SANA)Grant/award (A): 6,297 @ $0EDGAR
2026-06-054Sana Biotechnology, Inc. (SANA)Grant/award (A): 90,000 (derivative) @ $0EDGAR
2026-04-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 7,763 @ $0EDGAR
2026-01-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 6,157 @ $0EDGAR
2025-10-074Sana Biotechnology, Inc. (SANA)Grant/award (A): 5,628 @ $0EDGAR
2025-07-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 7,842 @ $0EDGAR
2025-06-094Sana Biotechnology, Inc. (SANA)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2025-04-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 16,339 @ $0EDGAR
2025-01-074Sana Biotechnology, Inc. (SANA)Grant/award (A): 14,285 @ $0EDGAR
2024-10-094Sana Biotechnology, Inc. (SANA)Grant/award (A): 5,938 @ $0EDGAR
2024-07-154/ASana Biotechnology, Inc. (SANA)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-07-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 4,911 @ $0EDGAR
2024-06-174Lyell Immunopharma, Inc. (LYEL)Grant/award (A): 130,000 (derivative) @ $0EDGAR
2024-06-074Sana Biotechnology, Inc. (SANA)Grant/award (A): 54,278 (derivative) @ $0EDGAR
2024-04-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 2,774 @ $0EDGAR
2024-03-194AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,678 @ $147.48 · Grant/award (A): 750 @ $147.48EDGAR
2024-01-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 4,901 @ $0EDGAR
2023-10-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 6,925 @ $0EDGAR
2023-09-084Lyell Immunopharma, Inc. (LYEL)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2023-07-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 4,152 @ $0EDGAR
2023-06-204Lyell Immunopharma, Inc. (LYEL)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2023-06-094Sana Biotechnology, Inc. (SANA)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2023-04-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 7,716 @ $0EDGAR
2023-03-204AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,658 @ $136.82 · Grant/award (A): 741 @ $136.82EDGAR
2023-01-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 6,702 @ $0EDGAR
2022-10-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 4,012 @ $0EDGAR
2022-09-094Lyell Immunopharma, Inc. (LYEL)Option exercise (M): 145,380 @ $0.10 · Option exercise (M): 145,380 (derivative) @ $0EDGAR
2022-07-074Sana Biotechnology, Inc. (SANA)Grant/award (A): 3,328 @ $0EDGAR
2022-06-104Lyell Immunopharma, Inc. (LYEL)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2022-06-084Sana Biotechnology, Inc. (SANA)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2022-04-064Sana Biotechnology, Inc. (SANA)Grant/award (A): 2,880 @ $0EDGAR
2022-03-214AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,785 @ $136.82 · Grant/award (A): 797 @ $136.82EDGAR
2022-02-254Lyell Immunopharma, Inc. (LYEL)Option exercise (M): 993,428 @ $0.10 · Option exercise (M): 993,428 (derivative) @ $0EDGAR
2021-06-234Lyell Immunopharma, Inc. (LYEL)Conversion (C): 546,806 · Conversion (C): 546,806 (derivative) @ $0EDGAR
2021-03-224AGILENT TECHNOLOGIES, INC. (A)Grant/award (A): 1,850 @ $121.59 · Grant/award (A): 822 @ $121.59EDGAR
2021-02-184/ASana Biotechnology, Inc. (SANA)Grant/award (A): 23,591 (derivative) @ $0EDGAR
2021-02-104Sana Biotechnology, Inc. (SANA)Conversion (C): 2,031,250 · Conversion (C): 1,075,000 (derivative) @ $0 · Conversion (C): 800,000 (derivative) @ $0 · Conversion (C): 156,250 (derivative) @ $0EDGAR
2021-02-054Sana Biotechnology, Inc. (SANA)Grant/award (A): 14,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1480212 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs